LAZMAR Scoring , Hysteroscopic MyomectomyNCT07578246
"Evaluating The Applicability of LASMAR Scoring in Predicting Surgical Outcomes Of Hysteroscopic Myomectomy"
An observational study of LAZMAR Scoring , Hysteroscopic Myomectomy, run by Ain Shams University.
Trial summary
This study aims to evaluate the applicability of the LASMAR scoring system, derived from hysteroscopy, in predicting surgical outcomes in patients undergoing hysteroscopic myomectomy for submucous fibroids. Read more about this study
- Who is it for?
- Ages 18 to 45 years, women only
- Conditions the study is for
- LAZMAR Scoring , Hysteroscopic Myomectomy
- What is being tested?
- Hysteroscopic Myomectomy
- Type of treatment
- Surgery or procedure
- How many people
- 88 participants
- Where
- No sites listed yet
- Study dates
- 1 Jun 2026to 1 Jul 2028
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- Women only
- Adult
Study population: Women undergoing hysteroscopic myomectomy for symptomatic uterine fibroids.
Who may be able to join
- Women aged 18-45 years
- Type 0,1,2 Fibroids according to Figo classification.
- Symptomatic submucous fibroids: Symptoms include abnormal uterine bleeding, pelvic pain or pressure symptoms, infertility or recurrent pregnancy loss.
- Fibroids size ≤ 5 cm in diameter
- Confirmed diagnosis of leiomyoma by ultrasound .
- Hemodynamically Stable Patients: Patients with no significant anemia.
Who cannot join
- Contraindications to hysteroscopy (e.g., Pregnancy, pyometra, active infection)
- Individuals with significant comorbidities (e.g., severe cardiovascular or respiratory diseases, bleeding diathesis).
- Cases requiring concurrent procedures (e.g., Laparoscopic surgeries).
- Fibroid Size>5 cm.
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
Ahmed Mohammed Selim, MD contact
About this study
Official title: Evaluating The Applicability of LASMAR Scoring in Predicting Surgical Outcomes Of Hysteroscopic Myomectomy"
This study aims to evaluate the applicability of the LASMAR scoring system, derived from hysteroscopy, in predicting surgical outcomes in patients undergoing hysteroscopic myomectomy for submucous fibroids.
Read the detailed description
This study aims to evaluate the applicability of LASMAR scoring in predicting surgical outcomes for cases of hysteroscopic myomectomy. By applying the LASMAR scoring system to patient , the study seeks to determine if the scoring can accurately predict operative time, completeness of resection, and complication rates.
- Being tested
- Hysteroscopic Myomectomy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Hysteroscopic MyomectomyProcedure or surgery
Hysteroscopic myomectomy is a minimally invasive surgical procedure used to remove fibroids that are located inside the uterine cavity (submucosal fibroids).
What is being measured
The primary outcome is the main question the study is designed to answer.
Correlation between preoperative parameters assessed using the Lasmar score and operative parameters, including operative time, number of sessions needed for complete resection, fluid deficit and intraoperative complications.
Correlation between preoperative parameters assessed using the Lasmar score and operative parameters, including operative time, number of sessions needed for complete resection, fluid deficit and intraoperative complications
Measured: 2 years
Secondary outcomes (2)
Postoperative Complications: Including infection, adhesions, volume overload.
Postoperative Complications: Including infection, adhesions, volume overload.
Measured: 2 years
Need for Further Interventions: Incidence of additional treatments like hormonal therapy
Need for Further Interventions: Incidence of additional treatments like hormonal therapy
Measured: 2 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 May 2026
- Study start1 Jun 2026 (estimated)
- Primary completion1 Jun 2028 (estimated)
- Study completion1 Jul 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for LAZMAR Scoring , Hysteroscopic MyomectomyStudies of the same condition, open and under way.
- More trials run by Ain Shams UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 88 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Ain Shams University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Yomna Ayman Salah Abbas, Ain Shams University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07578246
- Sponsor's protocol ID
- OBGYN-HYST-2026-01
- Status last verified
- May 2026
- First submitted
- 5 May 2026
- Last updated
- 11 May 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 11 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluating The Applicability of LASMAR Scoring in Predicting Surgical Outcomes Of Hysteroscopic Myomectomy"
- ClinicalTrials.gov ID
- NCT07578246
- Acronym / sponsor ID
- OBGYN-HYST-2026-01
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 88 participants (estimated)
- Lead sponsor
- Ain Shams UniversityUniversity, hospital or other
- Study start
- 1 Jun 2026 (estimated)
- Primary completion
- 1 Jun 2028 (estimated)
- Study completion
- 1 Jul 2028 (estimated)
- First posted
- 11 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to evaluate the applicability of the LASMAR scoring system, derived from hysteroscopy, in predicting surgical outcomes in patients undergoing hysteroscopic myomectomy for submucous fibroids.
Detailed description
This study aims to evaluate the applicability of LASMAR scoring in predicting surgical outcomes for cases of hysteroscopic myomectomy. By applying the LASMAR scoring system to patient , the study seeks to determine if the scoring can accurately predict operative time, completeness of resection, and complication rates.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 45 years
- Sex
- Female only
- Age groups
- Adult
- Study population
- Women undergoing hysteroscopic myomectomy for symptomatic uterine fibroids.
Key inclusion criteria (6 listed)
- Women aged 18-45 years
- Type 0,1,2 Fibroids according to Figo classification.
- Symptomatic submucous fibroids: Symptoms include abnormal uterine bleeding, pelvic pain or pressure symptoms, infertility or recurrent pregnancy loss.
- Fibroids size ≤ 5 cm in diameter
- Confirmed diagnosis of leiomyoma by ultrasound .
Key exclusion criteria (4 listed)
- Contraindications to hysteroscopy (e.g., Pregnancy, pyometra, active infection)
- Individuals with significant comorbidities (e.g., severe cardiovascular or respiratory diseases, bleeding diathesis).
- Cases requiring concurrent procedures (e.g., Laparoscopic surgeries).
- Fibroid Size>5 cm.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Hysteroscopic MyomectomyHysteroscopic myomectomy is a minimally invasive surgical procedure used to remove fibroids that are located inside the uterine cavity (submucosal fibroids). | Procedure or surgery | – |
Primary outcome
Correlation between preoperative parameters assessed using the Lasmar score and operative parameters, including operative time, number of sessions needed for complete resection, fluid deficit and intraoperative complications.
Time frame: 2 years
Correlation between preoperative parameters assessed using the Lasmar score and operative parameters, including operative time, number of sessions needed for complete resection, fluid deficit and intraoperative complications
2 secondary outcomes
Postoperative Complications: Including infection, adhesions, volume overload.
Time frame: 2 years
Need for Further Interventions: Incidence of additional treatments like hormonal therapy
Time frame: 2 years
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 May 2026.
- Individual participant dataSharing planned: Undecided
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Ahmed Mohammed Selim, MD contact
Questions about this trial
What is this clinical trial studying?
An observational study of LAZMAR Scoring , Hysteroscopic Myomectomy, run by Ain Shams University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 11 May 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Yomna Ayman Salah, Master degree (01060666006, yomnasalah@med.asu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Correlation between preoperative parameters assessed using the Lasmar score and operative parameters, including operative time, number of sessions needed for complete resection, fluid deficit and intraoperative complications. (time frame: 2 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 May 2026.